sameAs
Fexinidazole--a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sicknessThe anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasisFexinidazole: a potential new drug candidate for Chagas diseaseDetermination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studies.Antitrypanosomal activity of fexinidazole metabolites, potential new drug candidates for Chagas diseaseThe activity of fexinidazole (HOE 239) against experimental infections with Trypanosoma cruzi, trichomonads and Entamoeba histolytica.The use of the 2 substituted 5-nitroimidazole, Fexinidazole (Hoe 239) in the treatment of chronic T. brucei infections in mice.Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sicknessImproving the Quality of Host Country Ethical Oversight of International Research: The Use of a Collaborative 'Pre-Review' Mechanism for a Study of Fexinidazole for Human African Trypanosomiasis.Dose-dependent effect and pharmacokinetics of fexinidazole and its metabolites in a mouse model of human African trypanosomiasis.A DBS method for quantitation of the new oral trypanocidal drug fexinidazole and its active metabolites.Topical chemotherapy for experimental murine African CNS-trypanosomiasis: the successful use of the arsenical, melarsoprol, combined with the 5-nitroimidazoles, fexinidazole or MK-436.Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.Fexinidazole: A New Drug for African Sleeping Sickness on the Horizon.Oral fexinidazole for human African trypanosomiasis.Genotoxicity profile of fexinidazole--a drug candidate in clinical development for human African trypanomiasis (sleeping sickness).
P921
Q21144517-54EB5EEC-D87D-46A0-BC4D-F7835D787024Q24633734-A86511F0-B38C-48C9-A350-B911225889ADQ28484826-5ECD3210-53A9-474C-A27C-5560BE80DAE6Q33681753-AE797947-5E7C-40E3-A0F6-72C32700DD51Q34058185-2832B33B-4A1C-4DC2-8C01-C21AC0219357Q34259398-53CD6605-182E-4A6F-84F8-94FDCE8CBCA3Q34265044-FF09FBC3-0600-45BE-AB3A-FB10A26E7C59Q35598430-5A87585D-EAA5-46D6-BC18-E968A066435FQ38231319-C92A8CE2-F4DF-44A4-B144-6D07254C3C24Q38926650-D0010BAC-2D6D-4AB8-8130-F27F70AF7005Q46268194-ABEF03FB-7CD8-41E7-82BB-022AE392FD3AQ46910544-31ABC130-D0BC-4DC8-ADC2-A2F9A0F7482FQ47637613-A34CD55E-E99A-47A6-A3FE-E370FA816DB1Q49596380-C4ECAEC0-46B6-4FD7-B181-EFE184BEA838Q49896872-EB5E96E7-26EC-4B51-B1BF-494B8EBB3ED8Q50027235-C9B24218-BE84-4CEF-891A-081F0472550E
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Feksinidatsoli
@fi
Feksinidazol
@sh
Feksinidazol
@sr
Fexinidazol
@de
Fexinidazole
@vi
fexinidazole
@en
フェキシニダゾール
@ja
type
label
Feksinidatsoli
@fi
Feksinidazol
@sh
Feksinidazol
@sr
Fexinidazol
@de
Fexinidazole
@vi
fexinidazole
@en
フェキシニダゾール
@ja
prefLabel
Feksinidatsoli
@fi
Feksinidazol
@sh
Feksinidazol
@sr
Fexinidazol
@de
Fexinidazole
@vi
fexinidazole
@en
フェキシニダゾール
@ja
P486
P592
P6366
P661
P662
P117
P2067
P231
59729-37-2
P232
P233
CN1C(=CN=C1COC2=CC=C(C=C2)SC)[N+](=O)[O-]
P234
1S/C12H13N3O3S/c1-14-11(13-7-12(14)15(16)17)8-18-9-3-5-10(19-2)6-4-9/h3-7H,8H2,1-2H3
P235
MIWWSGDADVMLTG-UHFFFAOYSA-N
P2566
100.207.619
P267
P274
C₁₂H₁₃N₃O₃S
P3117
DTXSID00208448
P486
P592
CHEMBL1631694
P6366
2780670076
P652
306ERL82IR